NCT04938856View on ClinicalTrials.gov

Bioequivalence of Lamnet (Lamotrigine)100mg Tablet With the Reference Product Lamictal 100mg (Lamotrigine) Tablet Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 4, 2020

Primary Completion Date

September 24, 2020

Study Completion Date

October 25, 2020

Conditions
Bioequivalence
Interventions
DRUG

Lamotrigine tablet

Lamotrigine 100 mg immediate release Tablet

Trial Locations (1)

75270

Center for Bioequivalence Studies and clinical research, Karachi

All Listed Sponsors
collaborator

The Searle Company LTD., Pakistan.

UNKNOWN

lead

University of Karachi

OTHER

NCT04938856 - Bioequivalence of Lamnet (Lamotrigine)100mg Tablet With the Reference Product Lamictal 100mg (Lamotrigine) Tablet Under Fasting Conditions | Biotech Hunter | Biotech Hunter